Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

PubWeight™: 7.40‹?› | Rank: Top 0.1%

🔗 View Article (PMID 10027448)

Published in Chest on February 01, 1999


M H Kollef1, G Sherman, S Ward, V J Fraser

Author Affiliations

1: Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Articles citing this

(truncated to the top 100)

Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother (2005) 5.35

Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis (2012) 5.24

Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol (2007) 3.51

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother (2005) 3.49

Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev (2005) 3.27

Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy. Crit Care Med (2015) 2.87

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis (2014) 2.65

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother (2007) 2.49

National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother (2004) 2.40

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care (2003) 2.38

Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother (2008) 2.32

An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med (2013) 2.23

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care (2010) 2.11

Clinical review: medication errors in critical care. Crit Care (2008) 2.10

Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care (2011) 1.91

Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother (2007) 1.91

Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev (2012) 1.84

Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag (2008) 1.79

Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J Clin Microbiol (2006) 1.74

Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2003) 1.68

Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol (2008) 1.68

Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol (2009) 1.63

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ (2004) 1.62

β-lactam antibiotic concentrations during continuous renal replacement therapy. Crit Care (2014) 1.59

Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2006) 1.50

Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care (2003) 1.46

Predictors of in-hospital mortality in elderly patients with bacteraemia admitted to an Internal Medicine ward. Int Arch Med (2011) 1.46

Rapid universal identification of bacterial pathogens from clinical cultures by using a novel sloppy molecular beacon melting temperature signature technique. J Clin Microbiol (2009) 1.44

Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial. Antimicrob Agents Chemother (2007) 1.43

General principles of antimicrobial therapy. Mayo Clin Proc (2011) 1.42

Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care (2006) 1.41

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2007) 1.40

Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ (2005) 1.36

Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia. Antimicrob Agents Chemother (2011) 1.35

Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care (2010) 1.33

Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis (2004) 1.33

Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care (2008) 1.28

Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother (2010) 1.27

Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock. Crit Care (2010) 1.26

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care (2014) 1.26

Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. Am J Physiol Regul Integr Comp Physiol (2005) 1.24

Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit Care (2009) 1.23

Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care (2012) 1.23

Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis (2011) 1.22

Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations? Antimicrob Agents Chemother (2013) 1.21

Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother (2011) 1.21

Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology (2011) 1.21

Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients. Clin Microbiol Rev (2007) 1.20

Antibiotic stewardship in the intensive care unit. Crit Care (2014) 1.18

Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care (2011) 1.17

Critical care in the emergency department: shock and circulatory support. Emerg Med J (2005) 1.17

Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Crit Care (2006) 1.15

Effect of antifungal therapy timing on mortality in cancer patients with candidemia. Antimicrob Agents Chemother (2009) 1.14

Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci (2010) 1.13

Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care (2012) 1.12

Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC Infect Dis (2008) 1.11

Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002. Antimicrob Agents Chemother (2004) 1.11

De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care (2010) 1.11

Enhanced diagnostic yields of bacteremia and candidemia in blood specimens by PCR-electrospray ionization mass spectrometry. J Clin Microbiol (2013) 1.10

Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis (2005) 1.09

Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections. Eur J Clin Microbiol Infect Dis (2011) 1.08

Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers. Antimicrob Agents Chemother (2005) 1.07

The antibiotic resistance profiles of bacterial strains isolated from patients with hospital-acquired bloodstream and urinary tract infections. Crit Care Res Pract (2012) 1.07

Therapeutic drug monitoring of antimicrobials. Br J Clin Pharmacol (2012) 1.06

Automated extraction improves multiplex molecular detection of infection in septic patients. PLoS One (2010) 1.06

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: risk factors and impact on outcomes. BMC Infect Dis (2012) 1.05

Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients. Antimicrob Agents Chemother (2009) 1.05

PCR-based rapid sepsis diagnosis effectively guides clinical treatment in patients with new onset of SIRS. Langenbecks Arch Surg (2011) 1.04

Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients. Eur J Clin Microbiol Infect Dis (2011) 1.03

Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol (2012) 1.02

Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay. Antimicrob Agents Chemother (2006) 1.02

Optimizing antibiotic therapy in the intensive care unit setting. Crit Care (2001) 1.02

Pharmacoeconomic analysis of microbiologic techniques for differentiating staphylococci directly from blood culture bottles. J Clin Microbiol (2008) 1.00

Predictors of positive blood cultures in critically ill patients: a retrospective evaluation. Croat Med J (2012) 0.99

Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLoS One (2013) 0.99

Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care (2013) 0.99

Emerging technologies for rapid identification of bloodstream pathogens. Clin Infect Dis (2014) 0.98

Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients. BMC Anesthesiol (2011) 0.97

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation. Crit Care (2009) 0.97

Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. J Antimicrob Chemother (2008) 0.97

Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial. Crit Care (2012) 0.97

Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection (2016) 0.97

Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes. Antimicrob Agents Chemother (2012) 0.96

Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal. Br J Clin Pharmacol (2011) 0.95

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. Antimicrob Agents Chemother (2005) 0.94

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy. Eur J Med Res (2010) 0.94

Variation in sepsis care: a wake-up call. Crit Care (2003) 0.93

Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob Agents Chemother (2006) 0.93

Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit Care (2005) 0.93

Detection and validation of volatile metabolic patterns over different strains of two human pathogenic bacteria during their growth in a complex medium using multi-capillary column-ion mobility spectrometry (MCC-IMS). Appl Microbiol Biotechnol (2013) 0.92

Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets. Antimicrob Agents Chemother (2011) 0.92

Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. Ann Pharmacother (2007) 0.92

Lack of effect of shorter turnaround time of microbiological procedures on clinical outcomes: a randomised controlled trial among hospitalised patients in the Netherlands. Eur J Clin Microbiol Infect Dis (2005) 0.91

Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of "stealth dosing". Infect Control Hosp Epidemiol (2007) 0.91

Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures. J Clin Microbiol (2004) 0.89

Prospective randomized trials affect the outcomes of intraabdominal infection. Ann Surg (2001) 0.89

Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity? Int J Mol Sci (2016) 0.88

[Diagnosis and therapy of sepsis]. Clin Res Cardiol (2006) 0.87

An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis. BMC Infect Dis (2012) 0.87

Articles by these authors

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51

Electron microscopical reconstruction of the anterior sensory anatomy of the nematode Caenorhabditis elegans.?2UU. J Comp Neurol (1975) 6.58

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10

The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest (1998) 5.98

A global profile of germline gene expression in C. elegans. Mol Cell (2000) 5.97

Chemotaxis by the nematode Caenorhabditis elegans: identification of attractants and analysis of the response by use of mutants. Proc Natl Acad Sci U S A (1973) 4.76

Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med (1999) 4.15

Fertilization and sperm competition in the nematode Caenorhabditis elegans. Dev Biol (1979) 3.78

An investigation into the effectiveness of an early intervention method for delayed language development in young children. Int J Lang Commun Disord (2000) 3.68

Earliest Homo. Nature (1992) 3.52

Antibiotic resistance in the intensive care unit. Ann Intern Med (2001) 3.40

Characterization of temperature-sensitive, fertilization-defective mutants of the nematode caenorhabditis elegans. Genetics (1978) 2.68

Intersex, a temperature-sensitive mutant of the nematode Caenorhabditis elegans. Dev Biol (1978) 2.62

Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med (2001) 2.35

Larger sperm outcompete smaller sperm in the nematode Caenorhabditis elegans. Proc Biol Sci (1998) 2.35

Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun (1990) 2.32

Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial. Ann Intern Med (1995) 2.26

Sperm morphogenesis in wild-type and fertilization-defective mutants of Caenorhabditis elegans. J Cell Biol (1981) 2.18

Evaluation of an inspiratory muscle trainer in healthy humans. Respir Med (2001) 2.16

The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest (1998) 2.15

Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration. Trans R Soc Trop Med Hyg (1993) 2.15

Vesicle fusion, pseudopod extension and amoeboid motility are induced in nematode spermatids by the ionophore monensin. Cell (1980) 2.09

Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol (1999) 2.03

Fitness to practise: Unbelievably arrogant. Br Dent J (2014) 2.03

Developmental genetics of chromosome I spermatogenesis-defective mutants in the nematode Caenorhabditis elegans. Genetics (1988) 2.01

An expert system for culture-based infection control surveillance. Proc Annu Symp Comput Appl Med Care (1993) 1.98

Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J (2010) 1.97

The initiation of spermiogenesis in the nematode Caenorhabditis elegans. Dev Biol (1983) 1.89

The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest (2000) 1.85

DNA processing in temperature-sensitive morphogenic mutants of HSV-1. Virology (1987) 1.79

Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature. Heart (1996) 1.79

The influence of access to a private attending physician on the withdrawal of life-sustaining therapies in the intensive care unit. Crit Care Med (1999) 1.77

Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis. Open AIDS J (2008) 1.74

Methods for fractionation and scintillation counting of radioisotope-labeled polyacrylamide gels. Anal Biochem (1970) 1.74

Evolution of sperm size in nematodes: sperm competition favours larger sperm. Proc Biol Sci (1999) 1.73

The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol (1995) 1.72

ENCORE: the effect of nutrient enrichment on coral reefs. Synthesis of results and conclusions. Mar Pollut Bull (2001) 1.69

A representational approach to patient education. J Nurs Scholarsh (2001) 1.68

Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype. Gastroenterology (1999) 1.67

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Caenorhabditis elegans spermatozoan locomotion: amoeboid movement with almost no actin. J Cell Biol (1982) 1.66

The impact of the introduction of a rapid D-dimer assay on the diagnostic evaluation of suspected pulmonary embolism. Arch Intern Med (2001) 1.65

Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol (2001) 1.65

The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest (1997) 1.62

A nematode gene required for sperm vesicle fusion. J Cell Sci (1997) 1.62

Genetic and environmental conditions that increase longevity in Caenorhabditis elegans decrease metabolic rate. Proc Natl Acad Sci U S A (1999) 1.60

Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep (1992) 1.59

Sperm precedence in a hermaphroditic nematode (Caenorhabditis elegans) is due to competitive superiority of male sperm. Experientia (1995) 1.58

What role for statins? A review and economic model. Health Technol Assess (1999) 1.53

Antiviral chemoprophylaxis after occupational exposure to human immunodeficiency virus: why, when, where, and what. Am J Ophthalmol (1997) 1.52

Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212. J Pharmacol Exp Ther (1994) 1.52

Broad oxygen tolerance in the nematode Caenorhabditis elegans. J Exp Biol (2000) 1.51

A significant new contribution to radical head and neck surgery. The argon beam coagulator as an effective means of limiting blood loss. Arch Otolaryngol Head Neck Surg (1989) 1.50

Which orthodontic archwire sequence? A randomized clinical trial. Eur J Orthod (2006) 1.50

Internal or external wall diameter for abdominal aortic aneurysm screening? Ann R Coll Surg Engl (2010) 1.49

Initiation of spermiogenesis in C. elegans: a pharmacological and genetic analysis. Dev Biol (1989) 1.48

The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest (2001) 1.48

Monoclonal antibodies that recognize a polypeptide antigenic determinant shared by multiple Caenorhabditis elegans sperm-specific proteins. J Cell Biol (1986) 1.47

Membrane and cytoplasmic proteins are transported in the same organelle complex during nematode spermatogenesis. J Cell Biol (1986) 1.47

Caenorhabditis elegans fertilization-defective mutants with abnormal sperm. Genetics (1980) 1.47

A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest (2000) 1.46

Assessing the viability of mutant and manipulated sperm by artificial insemination of Caenorhabditis elegans. Genetics (1994) 1.44

Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J Infect Dis (1998) 1.43

Lactose and fatty acid synthesis in lactating-rat mammary gland. Effects of starvation, re-feeding, and administration of insulin, adrenaline, streptozotocin and 2-bromo-alpha-ergocryptine. Biochem J (1984) 1.42

Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease. Eur Respir J (2003) 1.42

Use of the internet by infertile couples. Fertil Steril (2000) 1.40

A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals. J Virol (2001) 1.37

The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest (1998) 1.32

Vitamin A deficiency and mutations of RXRalpha, RXRbeta and RARalpha lead to early differentiation of embryonic ventricular cardiomyocytes. Development (1997) 1.31

The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts. Invest Ophthalmol Vis Sci (1992) 1.29

Delays in the suspicion and treatment of tuberculosis among hospitalized patients. Ann Intern Med (1999) 1.27

Membrane flow during nematode spermiogenesis. J Cell Biol (1982) 1.27

The Caenorhabditis elegans spe-26 gene is necessary to form spermatids and encodes a protein similar to the actin-associated proteins kelch and scruin. Genes Dev (1995) 1.26

Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.21

Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy. HIV Med (2006) 1.21

Increased competitiveness of nematode sperm bearing the male X chromosome. Proc Natl Acad Sci U S A (1997) 1.20

Hypercalcemia and gastric secretion in man. J Appl Physiol (1966) 1.19

The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis (1996) 1.18

Case-control study of congenital anomalies in children of cancer patients. BMJ (1993) 1.18

Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis (1998) 1.16

Chemicals, birth defects and stillbirths in New Brunswick: associations with agricultural activity. CMAJ (1988) 1.15

Hormonal therapies for early breast cancer: systematic review and economic evaluation. Health Technol Assess (2007) 1.12

A national survey of certified, recertified, and noncertified oncology nurses: comparisons and contrasts. Oncol Nurs Forum (1999) 1.11

A sperm-supplied product essential for initiation of normal embryogenesis in Caenorhabditis elegans is encoded by the paternal-effect embryonic-lethal gene, spe-11. Dev Biol (1989) 1.11

Early versus late tracheostomy in patients who require prolonged mechanical ventilation. Am J Crit Care (2000) 1.11

Relationships between certification and job perceptions of oncology nurses. Oncol Nurs Forum (2001) 1.10

Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Am J Clin Pathol (1994) 1.09

Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1992) 1.09

Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol (1999) 1.09

Bacillus subtilis ORF yybQ encodes a manganese-dependent inorganic pyrophosphatase with distinctive properties: the first of a new class of soluble pyrophosphatase? Microbiology (1998) 1.09

Assembly of bacteriophage T4 tail fibers. II. Isolation and characterization of tail fiber precursors. J Mol Biol (1970) 1.09

Identification of a large multigene family encoding the major sperm protein of Caenorhabditis elegans. J Mol Biol (1983) 1.08

The location of the major protein in Caenorhabditis elegans sperm and spermatocytes. Dev Biol (1982) 1.08

Genetic and molecular analysis of spe-27, a gene required for spermiogenesis in Caenorhabditis elegans hermaphrodites. Genetics (1996) 1.08

The Caenorhabditis elegans spe-6 gene is required for major sperm protein assembly and shows second site non-complementation with an unlinked deficiency. Genetics (1993) 1.08